Cardax Cash Flow - Annual (OTCBB:CDXI)

Add to My Stocks
$0.17 $0.02 (10.53%) CDXI stock closing price Sep 19, 2018 (Closing)

The Cardax cash flow statement helps investors understand how well the company is managing its cash flows. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Cardax profits and Cardax debt. Cardax had cash and cash equivalents of $- at beginning of the year and $2.23M at year end for 2017. Cardax cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Cardax had an outflow of $-2.08M from operating activities, $4.17M inflow due to financing activities, and $-0.01M outflow due to investing activities for 2017.

View details of Cardax cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20172016201520142013
Net Income Cash Flow
-1.98M-1.78M-4.25M-16.99M-4.36M
Depreciation Depletion Amortization Cash-Flow-----
Net Increase (Decrease) in Assets Liabilities-0.36M-1.15M-0.4M-
Cash From (used in) Discontinued Operations-----
Other Adjustments Net--1.57M11.66M-
Net Cash from (used by) Operating Activities
-2.08M-1.25M-1.5M-5.69M-4.12M
Increase (Decrease) in Prop Plant And Equipment-----0.03M
Acquisition Disposition of Subsidiaires-----
Increase (Decrease) in Investments-----
Other Cash Inflow (Outflow) from Investment Activities-0.01M-0.02M-0.02M--0.02M
Net Cash from (used by) Investment Activities
-0.01M-0.02M-0.01M--0.05M
Issuance (Purchase) of Equity Shares4.17M1.12M1.77M3.92M-
Issuance (Repayment) of Debt Securities-----
Increase (Decrease) in Bank & Other Borrowings---1.52M4.4M
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities-----
Net Cash from (used by) Financing Activities
4.17M1.12M1.8M5.44M4.4M
Effect of Exchange Rate Changes on Cash-----
Net Change in Cash & Cash Equivalents
2.07M-0.16M--0.18M-
Cash & Equivalents at Beginning of Year-----
Cash & Equivalents at Year End2.23M----
All figures in USD. M: Millions of USD, B: Billions of USD.

Cardax stock comparison chart provides an easy way to compare the stock price with peers along with details of Cardax stock price history.
The statement of cash flows can be categorized into three main sections:

  • Cardax had a Net Change in Cash and Cash Equivalents of $2.07M for the latest year 2017. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Cardax stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Cardax reported a negative operating cash flow of $-2.08M for 2017 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.01M for CDXI in last 2017 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $4.17M for Cardax.

Key Financial Ratios For Cardax Cash Flow

Annual Cash Flow Statements For Cardax Inc Peers

Nuvo Pharmaceuticals cash flow, XTL Biopharma cash flow